Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood

Kahan, 1989, Cyclosporine, N Engl J Med, 321, 1725, 10.1056/NEJM198912213212507 Klintmalm, 1981, Nephrotoxicity of cyclosporin A in liver and kidney transplant recipients, Lancet, 1, 470, 10.1016/S0140-6736(81)91851-1 Atkinson, 1983, Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes, Br J Haematol, 54, 59, 10.1111/j.1365-2141.1983.tb02067.x Feutren, 1992, Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases, N Engl J Med, 326, 654, 10.1056/NEJM199206183262502 Abraham, 1991, The role of intrarenal prostaglandins and angiotensin II in acute cyclosporineinduced vasoconstriction, Surgery, 110, 343 Mehring, 1992, Mechanisms of cyclosporin A-induced vasoconstriction in the isolated perfused rat kidney, Nephron, 60, 477, 10.1159/000186812 Mihatsch, 1988, Histopathology of cyclosporine nephrotoxicity, Transplant Proc, 20, 759 Mihatsch, 1983, Morphological findings in kidney transplants after treatment with cyclosporine, Transplant Proc, 15, 2821 Cohen, 1989, Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation, Eur J Haematol, 43, 207, 10.1111/j.1600-0609.1989.tb00284.x Guillemain, 1990, Thrombotic microangiopathy with reversible acute renal failure in a cardiac transplant recipient under cyclosporin, Clin Nephrol, 34, 237 Bonser, 1984, Cyclosporininduced haemolytic uraemic syndrome in liver allograft recipient [Letter], Lancet, 2, 1337, 10.1016/S0140-6736(84)90842-0 Van Buren, 1985, De novo hemolytic uremic syndrome in renal transplant patients immunosuppressed with cyclosporine, Surgery, 98, 54 Vanrenterghem, 1985, Thromboembolic complications and haemostatic changes in cyclosporintreated cadaveric kidney allograft recipients, Lancet, 1, 999, 10.1016/S0140-6736(85)91610-1 Bergentz, 1985, Venous thrombosis and cyclosporin, Lancet, 2, 101, 10.1016/S0140-6736(85)90205-3 Lafoz, 1990, Cyclosporin and deep venous thrombosis [Letter], Med Clin, 95, 117 Seeber, 1992, Thromb Res, 66, 373, 10.1016/0049-3848(92)90286-J Evans, 1995, Prothrombotic effects of cyclosporin A, in vitro and in vivo [Abstract], Thromb Haemost, 73, 908 Voss, 1988, Cyclosporine suppression of endothelial prostacyclin generation: a possible mechanism for nephrotoxicity, Transplantation, 45, 793, 10.1097/00007890-198804000-00025 Brown, 1987, Cyclosporine inhibits prostacyclin production by cultured human endothelial cells, Transplant Proc, 19, 1178 Brown, 1990, Inhibition of prostacyclin formation by cyclosporin is not due to reduced availability of arachidonic acid in membrane phospholipids of cultured human endothelial cells, Biochem Pharmacol, 39, 1136, 10.1016/0006-2952(90)90295-V Stahl, 1989, Cyclosporin A inhibits prostaglandin E2 formation by rat mesangial cells in culture, Kidney Int, 35, 1161, 10.1038/ki.1989.105 Stahl, 1986, Chronic cyclosporine A treatment reduces prostacyclin E2 formation in isolated glomeruli and papilla of rat kidneys, Clin Nephrol, 25, S78 Kurtz, 1987, Cyclosporin A inhibits PGE2 release from vascular smooth muscle cells, Biochem Biophys Res Commun, 147, 542, 10.1016/0006-291X(87)90965-X Grace, 1987, Cyclosporine A enhances platelet aggregation, Kidney Int, 32, 889, 10.1038/ki.1987.291 Perico, 1986, Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A, Am J Physiol, 251, 581 Coffmann, 1987, Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity, Transplantation, 43, 282, 10.1097/00007890-198702000-00023 Cohen, 1988, Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients, Thromb Res, 49, 91, 10.1016/0049-3848(88)90362-3 Frampton, 1983, In vivo platelet activation and in vitro hyperaggregability to arachidonic acid in renal allograft recipients, Kidney Int, 23, 506, 10.1038/ki.1983.48 Carlsen, 1985, Effect of cyclosporine A on procoagulant activity in mononuclear blood cells and monocytes in vitro, Clin Exp Immunol, 60, 407 Carlsen, 1987, Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporine, Transplantation, 43, 543, 10.1097/00007890-198704000-00018 Ryan, 1986, Charaterization and purification of mouse macrophage procoagulant-inducing factor, J Immunol, 137, 2864 Chung, 1991, The comparative effects of cyclosporine A and 16,16 dimethyl prostaglandin E2 on the allogeneic induction on monocyte/macrophage procoagulant activity and the cytokine macrophage procoagulant-inducing factor and interleukin-2, Immunology, 74, 670 Brown, 1986, Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity, Transplantation, 42, 150, 10.1097/00007890-198608000-00009 Charba, 1993, Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies, Am J Hematol, 42, 268, 10.1002/ajh.2830420306 Pfliegler, 1991, Successful cyclosporin therapy of acquired hemophilia caused by factor VIII (VIII: C) inhibiting antibody, Orv Hetil, 132, 1485 Yoshida, 1990, Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity, Transplantation, 50, 1066, 10.1097/00007890-199012000-00039 Zoja, 1986, Cyclosporine-induced endothelial cell injury, Lab Invest, 55, 455 Nitta, 1993, Cyclosporin A induces glomerular endothelial cell injury in vitro, Acta Pathol Jpn, 43, 367 Bunchman, 1991, Cyclosporine inhibition of adherence proteins and factor VIII of vascular endothelium, Transplant Proc, 23, 332 Jaffe, 1973, Culture of human endothelial cells derived from umbilical veins, J Clin Invest, 52, 2745, 10.1172/JCI107470 Burgess, 1985, Multiple forms of endothelial cell growth factor, J Biol Chem, 260, 11389, 10.1016/S0021-9258(17)39038-5 Biedermann, 1994, Human endothelial cells suppress prothrombin activation in non-anticoagulated whole blood in vitro, J Lab Clin Med, 124, 339 Kohler, 1995, The suppression of the coagulation of non-anticoagulated whole blood in vitro by human umbilical vein endothelial cells cultivated on microcarriers is not dependent on protein C activation, Thromb Haemostas, 73, 719, 10.1055/s-0038-1653847 Kohler, 1993, Human umbilical vein endothelial cells on microcarriers suppress thrombin generation in recalcified human citrated plasma in vitro [Abstract], Thromb Haemost, 69, 1250 Moldow, 1993, Induction of endothelial tissue factor by endotoxin and its precursors, Thromb Haemost, 70, 702, 10.1055/s-0038-1649653 Carlsen, 1988, Cytokine-induced procoagulant activity in monocytes and endothelial cells, 46, 575 Rodgers, 1983, Characterization of the effects of cultured vascular endothelial cells on the activation of blood coagulation, Blood, 61, 1155, 10.1182/blood.V61.6.1155.1155 Colman, 1987, Mechansims of platelet aggregation, 594 Mulder, 1994, Tumor necrosis factor-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix, Blood, 84, 1559, 10.1182/blood.V84.5.1559.1559 Moore, 1987, Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro, J Clin Invest, 79, 124, 10.1172/JCI112772 Garcia-Maldonado, 1991, Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine, Transplantation, 51, 701, 10.1097/00007890-199103000-00030 Busso, 1991, Refractory period phenomenon in the induction of tissue factor expression on endothelial cells, Blood, 78, 2027, 10.1182/blood.V78.8.2027.2027